Importantly, Hao et al. (2011) showed that RNAi targeting HIF-1α is effectively inhibiting the progression of oral squamous cell carcinoma and concluded that it may be used as a potent and specific therapy for oral cancer, especially in inhibiting and preventing cancer cell angiogenesis and survival [37]. Here, HIF1A is linked to lip and oral cavity carcinoma.